Skip to main content
Premium Trial:

Request an Annual Quote

University of Groningen Forms Synthetic Biology Center

NEW YORK (GenomeWeb News) – The University of Groningen in the Netherlands plans to invest €2 million ($3.1 million) over the next five years in its newly created synthetic biology research center, the university said in a statement Thursday.
 
The Center for Synthetic Biology will have three main areas of focus: "cell factories" for producing pharmaceuticals, antibiotics, and proteins; systems for controlled drug delivery and new diagnostics; and biosensors and biochips based on biological components.
 
The CSB will have four synthetic biology sections, and will be supported by the Zernike Institute for Advanced Materials, the Stratingh Institute for Chemistry, and the Groningen Biomolecular Sciences and Biotechnology Institute.
 
The university also plans to “launch an intensive recruitment campaign to attract top researchers,” and it plans to develop more outside relationships with academic and business partners as well.
 
Current participants in the CSB are biochemist Bert Poolman, molecular biologist Roel Bovenberg, microbiologist Lubbert Dijkhuizen, organic chemist Ben Feringa, physicist Jasper Knoester, and molecular microbiologist Arnold Driessen. Poolman also is director of the CSB.
 
The university said it is focusing on synthetic biology because it will be the “third technological revolution,” after the microchip and the discovery of the structure of DNA.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.